Demirtas E

ORCID: 0000-0003-0853-0623 · 1 paper in corpus

2025

Outcomes of Ultimpro Testing Implementation for Patients With Unexplained Recurrent Implantation Failure: A Single-Center Retrospective Cohort Study.

American journal of reproductive immunology (New York, N.Y. : 1989) ·doi:10.1111/aji.70131

ProblemA proportion of patients with unexplained recurrent implantation failure (uRIF) may have endometrial immune dysregulation amenable to treatment. Ultimpro (Matrice lab Innove, Paris, France) is an endometrial immunophenotype test whic…